Table 6 Comparison of cytogenetic prognostic groups in MDS
Authors | This study | Schanz [15] | Greenberg [12] 2012 | Berggren [18] | Miyazaki [19] (≥ 40 years) | Wang [21] | Qu [22] | Mahmood [28] | Gupta [30] | |
|---|---|---|---|---|---|---|---|---|---|---|
Year | 2021 | 2012 | 2018 | 2018 | 2021 | 2012 | 2018 | 2017 | ||
Country | India | Germany | USA | Norway | Australia | Japan | China | China | Pakistan | India |
No. of patients | 936 | 2754 | 7012 | 973 | 5838 | 300 | 665 | 532 | 178 | 86 |
Very good prognosis | 2 | 2.9 | 4 | 6 | 3.6 | 1 | 1.8 | 2 | 5.6 | 1.1 |
Good prognosis | 55.6 | 65.7 | 72 | 56 | 72.2 | 71.3 | 61.2 | 43 | 62.9 | 56.9 |
Normal karyotypes | 45 | 55.1 | NA | 49 | 62.7 | 65.3 | 55.2 | 35 | 53.4 | 50 |
Intermediate prognosis | 16.2 | 19.2 | 13 | 15 | 13.3 | 17 | 25 | 36 | 15.2 | 11.6 |
Poor prognosis | 15 | 5.4 | 4 | 8 | 4.1 | 4.3 | 7.6 | 7 | 12.9 | 13.9 |
Very poor prognosis | 11.2 | 6.8 | 7 | 15 | 5.9 | 6.3 | 4.4 | 12 | 3.4 | 16.2 |